These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 7627965)
1. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Milas L; Hunter NR; Mason KA; Milross CG; Saito Y; Peters LJ Cancer Res; 1995 Aug; 55(16):3564-8. PubMed ID: 7627965 [TBL] [Abstract][Full Text] [Related]
2. Irradiation with Carbon Ions Effectively Counteracts Hypoxia-related Radioresistance in a Rat Prostate Carcinoma. Glowa C; Bendinger AL; Euler-Lange R; Peschke P; Brons S; Debus J; Karger CP Int J Radiat Oncol Biol Phys; 2024 Nov; 120(3):875-883. PubMed ID: 38750905 [TBL] [Abstract][Full Text] [Related]
3. The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia. Gallez B Front Pharmacol; 2022; 13():853568. PubMed ID: 35910347 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapeutic effects on breast tumor hemodynamics revealed by eigenspectra multispectral optoacoustic tomography (eMSOT). Liapis E; Karlas A; Klemm U; Ntziachristos V Theranostics; 2021; 11(16):7813-7828. PubMed ID: 34335966 [TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II). PelvEx Collaborative BJS Open; 2021 May; 5(3):. PubMed ID: 34089596 [TBL] [Abstract][Full Text] [Related]
6. Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer. Damiana TST; Dalm SU Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34067215 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation. Ho AY; Ballangrud A; Li G; Gupta GP; McCormick B; Gewanter R; Gelblum D; Zinovoy M; Mueller B; Mychalczak B; Dutta P; Borofsky K; Parhar P; Reyngold M; Braunstein LZ; Chawla M; Krause K; Freeman N; Siu CT; Cost Z; Arnold BB; Zhang Z; Powell SN Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1100-1108. PubMed ID: 30508620 [TBL] [Abstract][Full Text] [Related]
9. Transportable system enabling multiple irradiation studies under simultaneous hypoxia in vitro. Metsälä O; Kreutzer J; Högel H; Miikkulainen P; Kallio P; Jaakkola PM Radiat Oncol; 2018 Nov; 13(1):220. PubMed ID: 30424810 [TBL] [Abstract][Full Text] [Related]
10. Quantitative diffuse reflectance spectroscopy of short-term changes in tumor oxygenation after radiation in a matched model of radiation resistance. Diaz PM; Jenkins SV; Alhallak K; Semeniak D; Griffin RJ; Dings RPM; Rajaram N Biomed Opt Express; 2018 Aug; 9(8):3794-3804. PubMed ID: 30338156 [TBL] [Abstract][Full Text] [Related]
11. A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol. Chen Y; Zhu Z; Zhao W; Li L; Ye J; Wu C; Tang H; Lin Q; Li J; Xia Y; Li Y; Zhou J; Zhao K Radiat Oncol; 2018 Feb; 13(1):33. PubMed ID: 29482649 [TBL] [Abstract][Full Text] [Related]
12. KPU-300, a Novel Benzophenone-Diketopiperazine-Type Anti-Microtubule Agent with a 2-Pyridyl Structure, Is a Potent Radiosensitizer That Synchronizes the Cell Cycle in Early M Phase. Okuyama K; Kaida A; Hayashi Y; Hayashi Y; Harada K; Miura M PLoS One; 2015; 10(12):e0145995. PubMed ID: 26716455 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of fractionated and repeated sonodynamic therapy by using dual frequency for murine model of breast adenocarcinoma. Alamolhoda M; Mokhtari-Dizaji M J Ther Ultrasound; 2015; 3():10. PubMed ID: 26124951 [TBL] [Abstract][Full Text] [Related]
14. Oxygen-carbon nanotubes as a chemotherapy sensitizer for paclitaxel in breast cancer treatment. Wang Y; Wang C; Jia Y; Cheng X; Lin Q; Zhu M; Lu Y; Ding L; Weng Z; Wu K PLoS One; 2014; 9(8):e104209. PubMed ID: 25089613 [TBL] [Abstract][Full Text] [Related]
15. Towards predicting the response of a solid tumour to chemotherapy and radiotherapy treatments: clinical insights from a computational model. Powathil GG; Adamson DJ; Chaplain MA PLoS Comput Biol; 2013; 9(7):e1003120. PubMed ID: 23874170 [TBL] [Abstract][Full Text] [Related]
16. Electron paramagnetic resonance highlights that the oxygen effect contributes to the radiosensitizing effect of paclitaxel. Danhier F; Danhier P; Magotteaux N; De Preter G; Ucakar B; Karroum O; Jordan B; Gallez B; Préat V PLoS One; 2012; 7(7):e40772. PubMed ID: 22808261 [TBL] [Abstract][Full Text] [Related]
17. Quantitative immunohistochemistry for evaluating the distribution of Ki67 and other biomarkers in tumor sections and use of the method to study repopulation in xenografts after treatment with paclitaxel. Fung AS; Jonkman J; Tannock IF Neoplasia; 2012 Apr; 14(4):324-34. PubMed ID: 22577347 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant treatment in rectal cancer: actual status. Garajová I; Di Girolamo S; de Rosa F; Corbelli J; Agostini V; Biasco G; Brandi G Chemother Res Pract; 2011; 2011():839742. PubMed ID: 22295206 [TBL] [Abstract][Full Text] [Related]